Found: 15
Select item for more details and to access through your institution.
In Systemic Sclerosis Patients, Peripheral Blood CD21 low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 9, p. 1334, doi. 10.3390/jpm13091334
- By:
- Publication type:
- Article
Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 2, p. 309, doi. 10.3390/jpm13020309
- By:
- Publication type:
- Article
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 10, p. 1737, doi. 10.3390/jpm12101737
- By:
- Publication type:
- Article
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 9, p. N.PAG, doi. 10.3390/jpm12091420
- By:
- Publication type:
- Article
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/jpm12020284
- By:
- Publication type:
- Article
Serum markers of microbial translocation and intestinal damage in assessment of gastrointestinal tract involvement in systemic sclerosis.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01466-1
- By:
- Publication type:
- Article
Iloprost infusion reduces serological cytokines and hormones of hypoxia and inflammation in systemic sclerosis patients.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01374-4
- By:
- Publication type:
- Article
Type 2 cytokines and scleroderma interstitial lung disease.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 7, p. 3517, doi. 10.1007/s10238-023-01125-x
- By:
- Publication type:
- Article
Role of kinurenic acid in the systemic sclerosis renal involvement.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 5, p. 1713, doi. 10.1007/s10238-022-00962-6
- By:
- Publication type:
- Article
Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 3, p. 897, doi. 10.1007/s10238-022-00864-7
- By:
- Publication type:
- Article
In systemic sclerosis TAPSE/sPAP ratio is correlated with ventilatory efficiency and exercise capacity assessed by CPET.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 2, p. 365, doi. 10.1007/s10238-022-00804-5
- By:
- Publication type:
- Article
Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 3, p. 421, doi. 10.1007/s10238-021-00756-2
- By:
- Publication type:
- Article
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 9, p. 2755, doi. 10.1007/s10067-022-06219-7
- By:
- Publication type:
- Article
In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosis.
- Published in:
- Rheumatology, 2022, v. 61, n. 6, p. 2450, doi. 10.1093/rheumatology/keab748
- By:
- Publication type:
- Article
Serum-soluble ST2 and systemic sclerosis arthropathy.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 3, p. 871, doi. 10.1007/s10067-022-06367-w
- By:
- Publication type:
- Article